Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma [J]
Rikimaru T , Taketomi A , Yamashita Y , et al. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma [J]. Oncology , 2007, 72 (1/2) : 69-74.
The structure and function of histone deacetylases: The target for anti - Cancer therapy [J]
Zhang Y , Fang H , Jiao J , et al. The structure and function of histone deacetylases : the target for anti - cancer therapy [J]. Curr Med Chem, 2008, 15 (27) : 2840-2849.
(2008)Curr Med Chem, vol.15, Issue.27, pp. 2840-2849
High histone deacetylase 7 (HDAC 7) expression is significantly associated with adenocarcinomas of the pancreas [J]
Ouaïssi M , Sielezneff I, Silvestre R , et al. High histone deacetylase 7 (HDAC 7) expression is significantly associated with adenocarcinomas of the pancreas [J]. Ann Surg Oncol, 2008, 15(8) : 2318-2328.
Specific activity of class II histone deacetylases in human breast cancer cells [J]
Duong V , Bret C , Altucci L, et al. Specific activity of class II histone deacetylases in human breast cancer cells [J]. Mol Cancer Res, 2008 , 6(12) : 1908-1919.
Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis [J]
Bakin R E , Jung M O. Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis [J]. J Biol Chem, 2004, 279 ( 49 ) : 51218-51225.
(2004)J Biol Chem, vol.279, Issue.49, pp. 51218-51225
Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis [J]
Datta J , Kutay H , Nasser M W , et al. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis [J]. Cancer Res, 2008, 68 (13) : 5049-5058.
Antisense hypoxia - Inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma [J]
Liu F , Wang P , Jiang X , et al. Antisense hypoxia - inducible factor 1 alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma [J]. Cancer Sci, 2008, 99 (10) :2055-2061.